open access

Vol 8, No 2 (2019)
REVIEW ARTICLES
Published online: 2019-04-04
Get Citation

Measurement of glucose concentration in interstitial fluid — an alternative or a supplement to conventional blood glucose monitoring?

Oskar Kublin, Mariusz Stępień
DOI: 10.5603/DK.2019.0006
·
Clinical Diabetology 2019;8(2):121-126.

open access

Vol 8, No 2 (2019)
REVIEW ARTICLES
Published online: 2019-04-04

Abstract

The paper describes currently available interstitial glucose monitoring systems and discusses their advantages and disadvantages in comparison with conventional blood glucose measurements using glucose meters. Furthermore, it describes clinical trials assessing these systems in terms of their usefulness, safety and influence on therapeutic management in diabetes.

Abstract

The paper describes currently available interstitial glucose monitoring systems and discusses their advantages and disadvantages in comparison with conventional blood glucose measurements using glucose meters. Furthermore, it describes clinical trials assessing these systems in terms of their usefulness, safety and influence on therapeutic management in diabetes.

Get Citation

Keywords

interstitial glucose levels, diabetes, self-monitoring of glycemia, CGM, FGM

About this article
Title

Measurement of glucose concentration in interstitial fluid — an alternative or a supplement to conventional blood glucose monitoring?

Journal

Clinical Diabetology

Issue

Vol 8, No 2 (2019)

Pages

121-126

Published online

2019-04-04

DOI

10.5603/DK.2019.0006

Bibliographic record

Clinical Diabetology 2019;8(2):121-126.

Keywords

interstitial glucose levels
diabetes
self-monitoring of glycemia
CGM
FGM

Authors

Oskar Kublin
Mariusz Stępień

References (31)
  1. Cameron C, Coyle D, Ur E, et al. Cost-effectiveness of self-monitoring of blood glucose in patients with type 2 diabetes mellitus managed without insulin. CMAJ. 2010; 182(1): 28–34.
  2. Polskie Towarzystwo Diabetologiczne (PTD) Zalecenia kliniczne dotyczące postępowania u chorych na cukrzycę 2018. Stanowisko Polskiego Towarzystwa Diabetologicznego. Diabetologia Praktyczna 2018; 4, 1. : Rozdz. 3.
  3. Polskie Towarzystwo Diabetologiczne (PTD) Zalecenia kliniczne dotyczące postępowania u chorych na cukrzycę 2018. Stanowisko Polskiego Towarzystwa Diabetologicznego. Diabetologia Praktyczna 2018; 4, 1. : Rozdz. 4.
  4. Lipska KJ, Ross JS, Miao Y, et al. Potential overtreatment of diabetes mellitus in older adults with tight glycemic control. JAMA Intern Med. 2015; 175(3): 356–362.
  5. Komunikat Komisji w ramach wdrażania dyrektywy 98/79/WE Parlamentu Europejskiego i Rady w sprawie wyrobów medycznych używanych do diagnozy in vitro. 2016/C 173/04.
  6. https://www.pompy-medtronic.pl/system-minimed/ci%C4%85g%C5%82e-monitorowanie-glikemii/sensor-glukozy-enlite.
  7. https://www.pompy-medtronic.pl/system-minimed/pompy-insulinowe-minimed-640g.
  8. http://willcare.pl/page/5/2/DEXCOM.html.
  9. https://www.accu-chek.pl/pl/microsites/eversense/index.html.
  10. https://www.freestylelibre.pl/.
  11. https://www.ambrosiasys.com/how-it-works.
  12. https://miaomiao.cool/.
  13. Obwieszczenie Ministra Zdrowia z dnia 29 sierpnia 2018 r. w sprawie wykazu refundowanych leków, środków spożywczych specjalnego przeznaczenia żywieniowego oraz wyrobów medycznych na 1 września 2018 r. https://www.gov.pl/zdrowie/.
  14. Oskarsson P, Antuna R, Geelhoed-Duijvestijn P, et al. Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. Lancet. 2016; 388(10057): 2254–2263.
  15. Lind M, Polonsky W, Hirsch IB, et al. Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial. JAMA. 2017; 317(4): 379–387.
  16. Wojciechowski P, Ryś P, Lipowska A, et al. Efficacy and safety comparison of continuous glucose monitoring and self-monitoring of blood glucose in type 1 diabetes: systematic review and meta-analysis. Pol Arch Med Wewn. 2011; 121(10): 333–343.
  17. Foster NC, Miller KM, Tamborlane WV, et al. T1D Exchange Clinic Network. Continuous glucose monitoring in patients with type 1 diabetes using insulin injections. Diabetes Care. 2016; 39(6): e81–e82.
  18. Šoupal J, Petruželková L, Flekač M, et al. Comparison of Different Treatment Modalities for Type 1 Diabetes, Including Sensor-Augmented Insulin Regimens, in 52 Weeks of Follow-Up: A COMISAIR Study. Diabetes Technol Ther. 2016; 18(9): 532–538.
  19. Polonsky WH, Peters AL, Hessler D. The impact of real-time continuous glucose monitoring in patients 65 years and older. J Diabetes Sci Technol. 2016; 10(4): 892–897.
  20. Beers Cv, DeVries J, Kleijer S, et al. Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial. The Lancet Diabetes & Endocrinology. 2016; 4(11): 893–902.
  21. Beck RW, Hirsch IB, Laffel L, et al. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care. 2009; 32(8): 1378–1383.
  22. Zhong A, Choudhary P, McMahon C, et al. Effectiveness of automated insulin management features of the MiniMed 640G sensor-augmented insulin pump. Diabetes Technol Ther. 2016; 18(10): 657–663.
  23. New JP, Ajjan R, Pfeiffer AFH, et al. Continuous glucose monitoring in people with diabetes: the randomized controlled Glucose Level Awareness in Diabetes Study (GLADIS). Diabet Med. 2015; 32(5): 609–617.
  24. https://www.eversensediabetes.com/eversense-sensor/.
  25. Christiansen MP, Klaff LJ, Brazg R, et al. A Prospective Multicenter Evaluation of the Accuracy of a Novel Implanted Continuous Glucose Sensor: PRECISE II. Diabetes Technol Ther. 2018; 20(3): 197–206.
  26. Kropff J, Choudhary P, Neupane S, et al. Accuracy and Longevity of an Implantable Continuous Glucose Sensor in the PRECISE Study: A 180-Day, Prospective, Multicenter, Pivotal Trial. Diabetes Care. 2017; 40(1): 63–68.
  27. Bailey TS, Chang A, Christiansen M. Clinical accuracy of a continuous glucose monitoring system with an advanced algorithm. J Diabetes Sci Technol. 2015; 9(2): 209–214.
  28. Laffel L. Improved accuracy of continuous glucose monitoring systems in pediatric patients with diabetes mellitus: results from two studies. Diabetes Technol Ther. 2016; 18 Suppl 2: S223–S233.
  29. Christiansen MP, Garg SK, Brazg R, et al. Accuracy of a fourth-generation subcutaneous continuous glucose sensor. Diabetes Technol Ther. 2017; 19(8): 446–456.
  30. Reddy M, Jugnee N, Anantharaja S, et al. Switching from Flash Glucose Monitoring to Continuous Glucose Monitoring on Hypoglycemia in Adults with Type 1 Diabetes at High Hypoglycemia Risk: The Extension Phase of the I HART CGM Study. Diabetes Technol Ther. 2018; 20(11): 751–757.
  31. Damiano ER, McKeon K, El-Khatib FH, et al. A comparative effectiveness analysis of three continuous glucose monitors: the Navigator, G4 Platinum, and Enlite. J Diabetes Sci Technol. 2014; 8(4): 699–708.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl